Protego Biopharma, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-03.
Announced $130M on 2025-12-01; Form D shows $32.9M sold as of 2025-12-03. Announced vs filed
Protego Biopharma, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 3, 2025. The filing reports $32.94M sold. Its industry group is Other Health Care. It names Brent Warner (Executive Officer, Director), SHELLEY CHU (Director), EDWARD HURWITZ (Director) (SEC Form D, December 3, 2025).
Is this your company?
Sell to companies like Protego Biopharma, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Protego Biopharma, Inc.
Free to see. No signup.
More on the people and the money behind Protego Biopharma, Inc., from the filings we hold.
Other Health Care raises by companies based in California, filed in December 2025, largest first.
Get an email when Protego Biopharma, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Protego Biopharma, Inc. raises, hires or launches. No email unless you switch it on.
Watch Protego Biopharma, Inc. →Get the full cited report on Protego Biopharma, Inc.
What the filing shows about Protego Biopharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Protego Biopharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Protego Biopharma, Inc.'s address as 10945 Vista Sorrento Parkway, Suite 150, San Diego, CA 92130.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Protego Biopharma, Inc. See pricing
Protego Biopharma, Inc. is a registered filer with the SEC (CIK 1796909) and has filed since 2025-12-03. 1 filing is on record, the latest on 2025-12-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Protego Biopharma, Inc.'s Form D of 2025-12-03 names Brent Warner, Shelley Chu, Edward Hurwitz and 7 more as its officers, directors or promoters.
Its new offerings report $32.94M sold across 1 offering, as its own filings state.
Trailing twelve months. 871 filings in Other Health Care, totalled by week. The dot is this raise, $32.94M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Brent Warner is named as Executive Officer and Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Shelley Chu is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Edward Hurwitz is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Helen Kim is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Laura Brass is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Tim Lohoff is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Janwillem Naesens is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Saoussen Ben Halima is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Jeffery Kelly is named as Director on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
Hank Petrassi is named as Executive Officer on the Form D that Protego Biopharma, Inc. filed with the SEC on 3 December 2025, one of 10 people that filing names.
10 people named on the filing — 2 holding an executive role and 8 as directors only.
Named as of the 2025-12-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Protego Biopharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Protego Biopharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Protego Biopharma, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Protego Biopharma, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Protego Biopharma, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Protego Biopharma, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/protego-biopharma-inc-form-d-25000001